TNFAIP3 mutation may be associated with favorable overall survival for patients with T-cell lymphoma
Abstract Background T-cell lymphoma (TCL) is highly aggressive and has a poor prognosis; thus, it is worth exploring biomarkers that may predict clinical outcomes and investigate their potential role in developing targeted therapies. In this study, we characterized the mutation pattern of tumor necr...
Gorde:
| Egile Nagusiak: | , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMC
2021-09-01
|
| Saila: | Cancer Cell International |
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.1186/s12935-021-02191-5 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|